Phase 2 Readout
VNDA: Phase 2 Readout: nereus
December 31, 2026 · nereus. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Vanda Pharmaceuticals Inc. (VNDA)
- Drug
- nereus
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: nereus
- Drug
- nereus
- Indication
- prevention of vomiting induced by GLP-1 receptor agonists